Centurion Res Share Discussion Threads

[blackbear] 13/2/2008 18:22

Could be months, could be days look at NIS, next day I believe.

[bi1l] 13/2/2008 17:52

I suppose we'll now have to wait months before they let anyone know the position. All probably a fabrication to get the share price up abit. Self defeating because by the time they inform the market everyone will be fed up and the share price will have drifted and dropped to 3p again.

[zimzoot] 12/2/2008 15:00

Have a look at GGA...large trades

[bi1l] 12/2/2008 09:22

Thanks for that blackbear - I would have thought by now if the offer wasn't at least reasonable they would have rejected it, so here's hoping for £1 plus. Although the share price seems to have stalled a bit at 55 to 60p, but whether one can read anything into that or not I don't know.

[blackbear] 11/2/2008 21:50

bi1l - I don't think it's an MBO here or a desperate sale.
I would say CEN could raise another 5m at this price if they wanted to.

Tipped as a speculative BUY in the euro today rag and a german investor website.

Bb.

[sicilian_kan] 11/2/2008 21:24

Glaxo have been in this for years and have never shown an interest. There is a 0% chance of them buying blackbear.

[bi1l] 11/2/2008 18:57

Interesting articles blackbear. Do you know how long we have to wait before they let the market know what's happening ? I hope its not a management buyout - i wouldn't be pleased with that at all - just will mean everyone's been totally shafted.

[blackbear] 10/2/2008 21:38

Few more news links with some interesting name dropping included..

I read Glaxo has a 1.2% stake, would be nice to think the unthinkable.





Apart from Goldman Sach institutional investors are still fully involved, I feel the market has had this one wrong for at least 6 months.

[kalingalinga] 08/2/2008 22:32

not even at 2p pre consol price yet.

[blackbear] 08/2/2008 21:21

Pro chartist at work... :D

[pickymicky] 08/2/2008 07:20

topinfo is a clueless liar.

Please be aware that he is just a ramper with no information whatsoever.

[sicilian_kan] 07/2/2008 23:03

Blackbear, I suspect you are right about it being said tongue in cheek, but it was still an awfully naive thing for Goodman to say...quite Ratner-esque

[blackbear] 07/2/2008 23:01

sicillian, whos peddling now.. It was tongue in cheek ffs..

But it's obvious he does not expect to be hanging up his pipettes: "I am extremely happy with this latest deal. It's all go now," he said. "Yes, it's the biggest deal in the company's history, and I have got more up my sleeve.

"Eventually, people are going to wake up to the huge value in this company."

[gbh2] 07/2/2008 22:54

They always prefer to go out with a Golden Handshake and sod the share holders!

[sicilian_kan] 07/2/2008 22:47

Today is the six month anniversary of the following article:



In this article, Alan Goodman, Chair of CeNeS, says that he will retire in six months (i.e. today) if CeNeS's moment had not come (having said that he expects to sell the Japan/ONO deal worldwide for three to four times ONO).

Well, CeNeS's shares have halved since this article was published, even taking into account the recent minor pull back, so why have you not retired as promised Alan?

[kalingalinga] 07/2/2008 21:48

Wasnt the share price above £1 when Mr Goodman said the ONO deal underpinned the entire share price. Surely after a statement like that they couldnt let the whole lot go for less than £1; cash pressures or not.

[bi1l] 07/2/2008 15:25

Here we go, price going down so back to normal again!

Any ideas how long the wait will be to find out what's happening?

So many different prices being bandied about the offer could be anything from todays price to about £1.20 - and at £1.20 I STILL wont even break even ! But there we are its a darn site better than 30p going on 3p !

[dr biotech] 07/2/2008 08:03

from the idependant

The biotech tiddler CeNes Pharmaceuticals leapt on a bid approach yesterday.

The company has been developing a painkiller, M6G, which is about to enter trials in the US. The drug has fewer side-effects than morphine, so there could be strong demand if it is successful. But for some time CeNes has been looking for a partner to help fund the cost of those trials. It wants an up-front payment, along with future royalties. So far no one has come forward, and before yesterday's rise, the shares had fallen 80 per cent since last year.

The market has been losing patience with biotechs. They emerged in the mid-1990s hovering up millions of pounds of investors' money in the quest for miracle drugs. Few have been successful. Institutions have banged a few heads together and forced the merger of some players.

The 62 per cent jump in the price values CeNes at £11.3m. A big pharma willing to take a punt on M6G may have decided to buy the whole company rather than pay to enter into a partnership venture to develop one of its lead products.

Investors should sit tight

[sicilian_kan] 06/2/2008 23:11

Well, for starters, the "Potential" for M6G being $200m/year was based on research that pre-dates the failure of M6G.

Note that CeNeS describe the Phase III M6G trials as being "successful". What planet are they on. The Phase III trials were the second set of Phase III trials. They failed to meet a key end point. They are now having to do a third Phase III trial to get enough data to get the drug on the market. If they succeeded, they wouldn't need to do this! How can that be successful. The word is unqualified and misleading.

[barts] 06/2/2008 23:02

Sorry sk...have I missed something??? Maybe you would like to enlighten me!!

[sicilian_kan] 06/2/2008 22:53

BARTS, you know nothing about M6G

[barts] 06/2/2008 22:39

sk....I am not sure what you are trying to get at.....maybe just wanting people to accept a lower offer for this company!!!
In the case of M6G, it is not about it being in production yet but about who has the product,who wants the product and what potential in the future will it be? CEN know it works...they have the patent and they are not going to sell it cheap!! Potential for M6G alone is $200million PY!! Would you sell it for $25million....I think not....a fare price would probably be $100million and still cheap at that. At $100million CEN would be listing at $4.56....makes 58p look cheap IMO doesn't it......

[sicilian_kan] 06/2/2008 21:46

Blackbear, you are peddling mistruths. M6G is not going to be in production soon. In the US it is still in Phase I, and hoping to start Phase III in 2008. I.e. it is not in production. In the interims, it states that "CeNeS currently anticipates that MAA and NDA submissions for M6G could be made in 2009/10." That is submissions, not production.

As for Europe, CeNeS stated in their Annual Report that they were seeking a partner, and that the partner would be likely to refer to the Phase III US trials before filing in Europe, i.e. the same if not later deadlines.